Is AUPH a good stock to buy? We came across a bullish thesis on Aurinia Pharmaceuticals Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on AUPH. Aurinia Pharmaceuticals Inc.'s share was trading at $18.62 as of June 24th. AUPH’s trailing and forward P/E were 8.27 and 23.42 respectively according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people living with autoimmune...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.